Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The peritoneal membrane acts as a biological semi-permeable barrier utilized in peritoneal dialysis to remove metabolic waste and excess fluid from the blood of patients with renal failure [StatPearls, 2023]. Transport across this membrane is governed by the 'three-pore model,' which includes large pores for proteins, small pores for solutes like urea and creatinine, and ultra-small pores (Aquaporin-1) for water transport [Rippe, 1996; Ni, 2006]. The efficiency of this process is determined by the membrane's surface area and permeability, which can be assessed clinically using the Peritoneal Equilibration Test (PET) [Twardowski, 1987]. Chronic exposure to conventional dialysis solutions, particularly those with high glucose concentrations and glucose degradation products, can lead to structural changes such as mesothelial cell loss and fibrosis [Morelle, 2015]. These changes often result in ultrafiltration failure, a significant complication that may necessitate a transition to hemodialysis [Davies, 2001]. Therapeutic strategies focus on using biocompatible solutions to preserve the membrane's functional integrity over time [Cho, 2014].
Facilitation of passive diffusion and osmotic ultrafiltration across a semi-permeable biological barrier to remove uremic toxins and excess fluid [StatPearls, 2023].
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peritoneal membrane (PM) (PM).